Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/TN/Chattanooga

Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Chattanooga, TN

Studies commonly pay $75 to $4,500 per completed study

139 clinical trials are currently recruiting participants within 30 miles of Chattanooga. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

139studies recruiting

9+research centers nearby

4condition categories

Live from the NIH registry

Studies recruiting near Chattanooga right now

Top 25 of 139 recruiting studies, sorted by proximity — each links to its official registry page

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Generalized Myasthenia Gravis N/A Observational 500 participants sought

Clinical Trial Site — Chattanooga, Tennessee (3.8 mi) · Sponsor: Alexion Pharmaceuticals, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT04202341)

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Graves' Disease Phase 2 Interventional 240 participants sought

Site Number - 1042 — Chattanooga, Tennessee (3.8 mi) · Sponsor: Immunovant Sciences GmbH

See eligibility & contact on ClinicalTrials.gov (NCT06727604)

Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis

Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital Phase 3 Interventional 400 participants sought

Chattanooga Medical Research, Chattanooga — Chattanooga, Tennessee (3.8 mi) · Sponsor: pH-D Feminine Health LLC

See eligibility & contact on ClinicalTrials.gov (NCT07109869)

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

Focal Segmental Glomerulosclerosis Phase 2 Interventional 60 participants sought

Investigator Site #4 — Chattanooga, Tennessee (3.8 mi) · Sponsor: Akebia Therapeutics

See eligibility & contact on ClinicalTrials.gov (NCT07268638)

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer Phase 3 Interventional 186 participants sought

Erlanger Health, Inc. — Chattanooga, Tennessee (3.8 mi) · Sponsor: Genelux Corporation

See eligibility & contact on ClinicalTrials.gov (NCT05281471)

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

Type 1 Diabetes Mellitus With Hypoglycemia Phase 2 Interventional 186 participants sought

University Diabetes & Endocrine Consultants — Chattanooga, Tennessee (3.8 mi) · Sponsor: Zucara Therapeutics Inc.

See eligibility & contact on ClinicalTrials.gov (NCT05762107)

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Radiation Retinopathy, Visual Impairment Phase 3 Interventional 600 participants sought

Southeastern Retina Associates — Hixson, Tennessee (5.2 mi) · Sponsor: Jaeb Center for Health Research

See eligibility & contact on ClinicalTrials.gov (NCT05844982)

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought

Chattanooga Heart Institute — Chattanooga, Tennessee (3.8 mi) · Sponsor: Novo Nordisk A/S

See eligibility & contact on ClinicalTrials.gov (NCT06118281)

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Heart Failure Phase 3 Interventional 11,300 participants sought

Research Site — Cleveland, Tennessee (22.0 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06677060)

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Uterine Fibroids, Endometriosis Phase 3 Interventional 1,000 participants sought

Chattanooga — Chattanooga, Tennessee (3.8 mi) · Sponsor: Sumitomo Pharma Switzerland GmbH

See eligibility & contact on ClinicalTrials.gov (NCT05862272)

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 600 participants sought

Site 60 — Chattanooga, Tennessee (3.8 mi) · Sponsor: Merus B.V.

See eligibility & contact on ClinicalTrials.gov (NCT06496178)

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Metastatic Castration-resistant Prostatic Neoplasms Phase 3 Interventional 1,203 participants sought

Tennessee Oncology - Chattanooga — Chattanooga, Tennessee (3.8 mi) · Sponsor: Janssen Research & Development, LLC

See eligibility & contact on ClinicalTrials.gov (NCT07164443)

ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis

AChR-Ab Seropositive Generalized Myasthenia Gravis, Myasthenia Gravis (MG) Phase 2 Interventional 40 participants sought

Erlanger Health System — Chattanooga, Tennessee (3.8 mi) · Sponsor: argenx

See eligibility & contact on ClinicalTrials.gov (NCT07673627)

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Generalized Myasthenia Gravis Phase 3 Interventional 264 participants sought

Erlanger Health, Inc. - 1123255 — Chattanooga, Tennessee (3.8 mi) · Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

See eligibility & contact on ClinicalTrials.gov (NCT06463587)

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma Phase 2 Interventional 130 participants sought

Tennessee Oncology — Chattanooga, Tennessee (3.8 mi) · Sponsor: Hoffmann-La Roche

See eligibility & contact on ClinicalTrials.gov (NCT06806033)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought

T C Thompson Children's Hospital — Chattanooga, Tennessee (3.8 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT04322318)

ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Autosomal Dominant Polycystic Kidney Disease Phase 2 Interventional 240 participants sought

Nephrology Associates - Chattanooga - East Third Street — Chattanooga, Tennessee (3.8 mi) · Sponsor: Calico Life Sciences LLC

See eligibility & contact on ClinicalTrials.gov (NCT06902558)

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NASH With Fibrosis, MASH With Fibrosis Phase 3 Interventional 1,650 participants sought

Akero Clinical Study Site — Chattanooga, Tennessee (3.8 mi) · Sponsor: Akero Therapeutics, Inc

See eligibility & contact on ClinicalTrials.gov (NCT06215716)

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

Irritable Bowel Syndrome Phase 2 Interventional 420 participants sought

GSK Investigational Site — Chattanooga, Tennessee (3.8 mi) · Sponsor: GlaxoSmithKline

See eligibility & contact on ClinicalTrials.gov (NCT07519395)

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

Multiple Myeloma Phase 1, Phase 2 Interventional 123 participants sought

GSK Investigational Site — Chattanooga, Tennessee (3.8 mi) · Sponsor: GlaxoSmithKline

See eligibility & contact on ClinicalTrials.gov (NCT05714839)

Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome

Down Syndrome (DS), Keratoconus Phase 3 Interventional 225 participants sought

Woolfson Eye Institute — Chattanooga, Tennessee (3.8 mi) · Sponsor: Woolfson Eye Institute

See eligibility & contact on ClinicalTrials.gov (NCT07135167)

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

Advanced Breast Cancer Phase 3 Interventional 788 participants sought

Research Site — Chattanooga, Tennessee (3.8 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06380751)

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathic Pain Phase 3 Interventional 734 participants sought

M3 Wake Research - Chattanooga — Chattanooga, Tennessee (3.8 mi) · Sponsor: Vertex Pharmaceuticals Incorporated

See eligibility & contact on ClinicalTrials.gov (NCT07231419)

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Advanced Cancer, Metastatic Cancer Phase 1, Phase 2 Interventional 542 participants sought

Tennessee Oncology, PLLC — Chattanooga, Tennessee (3.8 mi) · Sponsor: Artios Pharma Ltd

See eligibility & contact on ClinicalTrials.gov (NCT04657068)

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Non-small Cell Lung Cancer Phase 3 Interventional 868 participants sought

Greco-Hainsworth Centers for Research ( Site 4034) — Chattanooga, Tennessee (3.8 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06077760)

Actively enrolling

Studies you may be able to join near Chattanooga

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Chattanooga

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

M3 Wake Research Chattanooga

★ 4.5

6035 Shallowford Rd, Chattanooga, TN 37421

(423) 698-4584

Website

"Great friendly staff, get paid for participating in qualified medical research."

— Tyler Yeager, 5★

Nova Research Trials

725 Glenwood Dr Ste 686, Chattanooga, TN 37404

(423) 703-0888

Website

Lynn Institute of Chattanooga

Located in the Missionary Ridge Medical Tower, 725 Glenwood Dr #888, Chattanooga, TN 37404

(423) 713-5966

Website

Chattanooga Research & Medicine

2205 McCallie Ave Ste 301, Chattanooga, TN 37404

(423) 643-2253

Website

Chattanooga Medical Research

★ 5.0

929 Spring Creek Rd, Chattanooga, TN 37412

(423) 648-7794

Website

Wilkins Research Services

★ 4.0

1730 Gunbarrel Rd, Chattanooga, TN 37421

(423) 894-9478

Website

"I had my very first focus group today and I was nervous since I have never done anything like his before. They were extremely sweet, offered us drink…"

— Leila Parker, 5★

Erlanger Endocrinology

★ 2.3

979 E 3rd St Ste A-550, Chattanooga, TN 37403

(423) 778-8224

Website

"Have an appointment today after waiting for 3 months but I haven't been able to get ahold of anyone at the office. They absolutely suck . Please if …"

— sticky mess, 1★

Southeast Clinical Research Center

1102 W Waugh St, Dalton, GA 30720

(706) 913-1779

Website

Scenic City Neurotherapy and Ketamine Center

★ 4.9 (82 reviews)

7405 Shallowford Rd STE 240, Chattanooga, TN 37421

(423) 228-0579

Website

"Exceptional staff across the board. Charles and Brian are incredible providers, Connie, the receptionist is a joy to talk to and be welcomed by every…"

— James Dietzen, 5★

Clinical trials in Chattanooga: what's recruiting

The Chattanooga area currently has 139 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Chattanooga, the most active research areas are:

Cancer & Oncology9 studies
Liver & Kidney3 studies
Diabetes & Metabolism2 studies
Heart & Vascular2 studies

Every listing shows the study phase, the recruiting site and its distance from Chattanooga, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Chattanooga

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Chattanooga participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Chattanooga pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Do I need to be sick to join a clinical trial in Chattanooga?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Chattanooga safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

What is the difference between a research center and a hospital study in Chattanooga?

Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Chattanooga

Other metros within reach

Murfreesboro, TN79 Huntsville, AL95 Atlanta, GA1,722 Knoxville, TN236 Gainesville, GA149 Nashville, TN1,336 Birmingham, AL984 Athens, GA75

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Chattanooga Bladder Issues Due To Spinal Cord Injury in Chattanooga All conditions

More of TN

Nashville1,336 Memphis583 Knoxville236 Murfreesboro79 Clarksville8

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts